Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide
Unique ID
C116017
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C116017
Entry Term(s)
KCL1998001079
KRP 297
KRP-297
KRP297
L 410198
L-410198
L410198
MK 767
MK-767
MK767 cpd
Registry Numbers
213252-19-8
Previous Indexing
*THIAZOLES (1998-2006)
Heading Mapped to
*Thiazolidines
Frequency
12
Note
an antihyperlipidemic agent that also functions as an insulin sensitizer, PPARalpha agonist, and PPARgamma agonist; structure in first source
Source
Diabetes 1998 Dec;47(12):1841-7
Date of Entry
1998/12/18
Revision Date
2006/09/22
5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide Preferred
MK 767 Narrower
L 410198 Narrower
KRP 297 Narrower
KCL1998001079 Narrower
page delivered in 0.005s